Tianjin Zhong Xin Pharma posts 6% rise in FY20 earnings to $135.8 mil | The Edge Singapore
2021-03-30T10:04:23-04:00March 30th, 2021|
Related Posts
-
IBM plots US$730 million expansion of Canadian semiconductor site
April 26th, 2024 -
Yeo Guat Kwang, John Chen retiring from corporate boards
April 26th, 2024 -
US: Wall St opens higher
April 26th, 2024